Biodistribution and Safety of the PET Probes [18F]FPRGD2 and [18F]FPPRGD2
Status:
Suspended
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to conduct a pilot test of a new tracer in healthy human
volunteers to define normal tracer biodistribution (where the tracer goes), stability (how
much metabolises), pharmacokinetics (how much stays in which organs and for how long), and
radiation dosimetry (organ radiation dose). The same radiopharmaceutical will then be tested
in cancer patients.